gadolinium has been researched along with sirolimus in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cho, YS; Chun, YS; Kim, CH; Kim, MS; Park, JW | 1 |
Barkhof, F; Geurts, JJ; Guttmann, CR; Knol, DL; Meier, DS; Moraal, B; Pouwels, PJ; Uitdehaag, BM; van den Elskamp, IJ; van Schijndel, RA; Vrenken, H | 1 |
Astill, D; De Rosa, N; Marshman, G; Ross, C | 1 |
1 trial(s) available for gadolinium and sirolimus
Article | Year |
---|---|
Long-interval T2-weighted subtraction magnetic resonance imaging: a powerful new outcome measure in multiple sclerosis trials.
Topics: Adult; Brain; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gadolinium; Humans; Image Processing, Computer-Assisted; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Outcome Assessment, Health Care; Protein Kinase Inhibitors; Sirolimus; Statistics, Nonparametric | 2010 |
2 other study(ies) available for gadolinium and sirolimus
Article | Year |
---|---|
Early expression of myocardial HIF-1alpha in response to mechanical stresses: regulation by stretch-activated channels and the phosphatidylinositol 3-kinase signaling pathway.
Topics: Androstadienes; Animals; Cell Nucleus; Endothelial Growth Factors; Enzyme Inhibitors; Gadolinium; Gene Expression Regulation; Hypoxia-Inducible Factor 1, alpha Subunit; In Vitro Techniques; Ion Channels; Lymphokines; Male; Myocardial Ischemia; Myocardium; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Sirolimus; Specific Pathogen-Free Organisms; Stress, Mechanical; Transcription Factors; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Ventricular Function, Left; Wortmannin | 2002 |
Nephrogenic systemic fibrosis in a gadolinium-naïve patient: successful treatment with oral sirolimus.
Topics: Administration, Oral; Female; Gadolinium; Humans; Immunosuppressive Agents; Middle Aged; Nephrogenic Fibrosing Dermopathy; Sirolimus | 2015 |